🔎 Trials Near Me

Akèy › Amiloidoz › Texas › Dallas

Etid klinik pou Amiloidoz nan Dallas, TX

9 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Ap rekriteEtid obsèvasyon
  • Research Site, Dallas
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Ap rekriteFaz 3
  • Clinical Trial Site, Dallas
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Ap rekriteFaz 3
  • Clinical Trial Site, Dallas
Laj 18 a 85 · Tout sèks · Mizajou Sep 15, 2026 · NCT07223203

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

Ap rekriteEtid obsèvasyon
  • Clinical Trial Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07358078

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Ap rekriteEtid obsèvasyon
  • University of Texas Southwestern Medical Center, Dallas
Laj 30 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT05489549

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Ap rekriteFaz 1/2
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05145816

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • University of Texas Southwestern, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Ap rekriteFaz 3
  • Baylor Scott & White Research Institute, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Ap rekriteEtid obsèvasyon
  • UT Southwestern Medical Center, Dallas
Laj 30 a 80 · Tout sèks · Mizajou Jan 7, 2026 · NCT07196839

Etid Amiloidoz nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.